Chris Martin is the founder of ADC Therapeutics. ADC Therapeutics has raised $65M in total funding. Latest round: Series A.
Chris Martin, DPhil, is the former CEO of ADC Therapeutics. He currently serves as the Board Chair for Tagworks Pharmaceuticals, a company specializing in Click-to-Release chemistry for systemic therapies. Tagworks recently secured $65 million in Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide